|
ARNT2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.89159832031783E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.93329999073921E-09 |
| Normal-vs-Stage2 |
6.32238705833288E-12 |
| Normal-vs-Stage3 |
4.41802150419335E-12 |
| Normal-vs-Stage4 |
1.58344999999782E-05 |
| Stage1-vs-Stage2 |
1.670270E-02 |
| Stage1-vs-Stage3 |
1.145800E-02 |
| Stage1-vs-Stage4 |
5.831600E-01 |
| Stage2-vs-Stage3 |
7.144600E-01 |
| Stage2-vs-Stage4 |
6.782000E-01 |
| Stage3-vs-Stage4 |
4.709800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.4879999716585E-10 |
| Normal-vs-AfricanAmerican |
7.55610018998709E-10 |
| Normal-vs-Asian |
1.78429999999619E-05 |
| Caucasian-vs-AfricanAmerican |
5.680800E-01 |
| Caucasian-vs-Asian |
4.418300E-02 |
| AfricanAmerican-vs-Asian |
1.047640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.67144076357317E-12 |
| Normal-vs-Female |
2.83599999995054E-06 |
| Male-vs-Female |
2.800000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.953290E-04 |
| Normal-vs-Extreme_Weight |
2.21329998773001E-09 |
| Normal-vs-Obese |
8.5634055402295E-11 |
| Normal-vs-Extreme_Obese |
3.55469999999691E-05 |
| Normal_Weight-vs-Extreme_Weight |
3.307400E-01 |
| Normal_Weight-vs-Obese |
5.640000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.608600E-01 |
| Extreme_Weight-vs-Obese |
4.701800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.914200E-01 |
| Obese-vs-Extreme_Obese |
6.805600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.83250090049592E-11 |
| Normal-vs-Age(41-60Yrs) |
2.58339999947843E-07 |
| Normal-vs-Age(61-80Yrs) |
1.28099975071905E-10 |
| Normal-vs-Age(81-100Yrs) |
2.09560000463682E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.524200E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.489200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.465000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.127500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.900800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.007700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.16589999876737E-08 |
| Normal-VS-KIRP CIMP |
1.10730313807039E-11 |
| Normal-VS-Unclassified PRCC |
3.60609999972006E-07 |
| Type1 PRCC-VS-Type2 PRCC |
7.357800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.302900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.116560E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.308560E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.000000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.339280E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.3815619455454E-13 |
| Normal-vs-N1 |
8.2758000452543E-09 |
| Normal-vs-N2 |
1.664280E-02 |
| N0-vs-N1 |
2.190200E-01 |
| N0-vs-N2 |
3.336300E-02 |
| N1-vs-N2 |
4.076600E-01 |
|
|
